Logo image of NAOV

NANOVIBRONIX INC (NAOV) Stock Fundamental Analysis

NASDAQ:NAOV - US63008J7028 - Common Stock

5.395 USD
+0.36 (+7.26%)
Last: 8/22/2025, 8:26:09 PM
5.4 USD
+0.01 (+0.09%)
After Hours: 8/22/2025, 8:26:09 PM
Fundamental Rating

1

NAOV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. NAOV may be in some trouble as it scores bad on both profitability and health. NAOV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NAOV has reported negative net income.
NAOV had a negative operating cash flow in the past year.
In the past 5 years NAOV always reported negative net income.
In the past 5 years NAOV always reported negative operating cash flow.
NAOV Yearly Net Income VS EBIT VS OCF VS FCFNAOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

With a Return On Assets value of -12.72%, NAOV perfoms like the industry average, outperforming 56.68% of the companies in the same industry.
With a decent Return On Equity value of -15.73%, NAOV is doing good in the industry, outperforming 63.10% of the companies in the same industry.
Industry RankSector Rank
ROA -12.72%
ROE -15.73%
ROIC N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
NAOV Yearly ROA, ROE, ROICNAOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

NAOV's Gross Margin of 45.57% is on the low side compared to the rest of the industry. NAOV is outperformed by 61.50% of its industry peers.
In the last couple of years the Gross Margin of NAOV has grown nicely.
NAOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
NAOV Yearly Profit, Operating, Gross MarginsNAOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

1

2. Health

2.1 Basic Checks

NAOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NAOV has been increased compared to 1 year ago.
Compared to 5 years ago, NAOV has more shares outstanding
There is no outstanding debt for NAOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NAOV Yearly Shares OutstandingNAOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
NAOV Yearly Total Debt VS Total AssetsNAOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

NAOV has an Altman-Z score of -2.43. This is a bad value and indicates that NAOV is not financially healthy and even has some risk of bankruptcy.
NAOV's Altman-Z score of -2.43 is on the low side compared to the rest of the industry. NAOV is outperformed by 62.57% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that NAOV is not too dependend on debt financing.
NAOV has a Debt to Equity ratio of 0.07. This is in the better half of the industry: NAOV outperforms 63.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -2.43
ROIC/WACCN/A
WACC8.97%
NAOV Yearly LT Debt VS Equity VS FCFNAOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

A Current Ratio of 0.47 indicates that NAOV may have some problems paying its short term obligations.
NAOV has a worse Current ratio (0.47) than 94.65% of its industry peers.
A Quick Ratio of 0.22 indicates that NAOV may have some problems paying its short term obligations.
NAOV has a Quick ratio of 0.22. This is amonst the worse of the industry: NAOV underperforms 96.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.22
NAOV Yearly Current Assets VS Current LiabilitesNAOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.43% over the past year.
The Revenue has decreased by -6.53% in the past year.
NAOV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.00% yearly.
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.86%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%11.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAOV Yearly Revenue VS EstimatesNAOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NAOV Yearly EPS VS EstimatesNAOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 -200 -400 -600 -800 -1K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NAOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAOV Price Earnings VS Forward Price EarningsNAOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAOV Per share dataNAOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NAOV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANOVIBRONIX INC

NASDAQ:NAOV (8/22/2025, 8:26:09 PM)

After market: 5.4 +0.01 (+0.09%)

5.395

+0.36 (+7.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-18 2025-08-18
Earnings (Next)11-12 2025-11-12
Inst Owners2.31%
Inst Owner Change-1.49%
Ins Owners0.03%
Ins Owner Change0%
Market Cap4.32M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.62
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.82
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.11
FCFYN/A
OCF(TTM)-4.1
OCFYN/A
SpS3.33
BVpS44.59
TBVpS-5.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.72%
ROE -15.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.57%
FCFM N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.84%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.22
Altman-Z -2.43
F-Score3
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%11.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.54%
OCF growth 3YN/A
OCF growth 5YN/A